Digital detection method

By combining the relative motion between the probe and the container with optical detection equipment, rapid and efficient quantitative detection of biomolecules is achieved, solving the problems of long detection time and low sensitivity of ELISA and improving detection efficiency and sensitivity.

WO2024230236A1PCT designated stage expired Publication Date: 2024-11-14POLARITON LIFE TECHNOLOGIES LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/072034
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-01-08
Filing Date
2024-01-12
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Existing biomolecular detection methods, such as ELISA, are time-consuming, complex to operate, and have limited sensitivity, making it difficult to meet the demand for rapid and efficient detection.

Method used

A digital detection method is employed, utilizing the relative motion between the probe and the container to capture and detect the binding of ligands with the analyte, and combining this with optical detection equipment to count the number of luminescent markers, thereby achieving rapid quantitative detection of biomolecules.

Benefits of technology

It shortens the detection time, improves the detection sensitivity, expands the dynamic range of detection, and realizes rapid and efficient quantitative analysis of biomolecules.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024072034_14112024_PF_FP_ABST
    Figure CN2024072034_14112024_PF_FP_ABST
Patent Text Reader

Abstract

Provided in the embodiments of the present application is a digital detection method. The method comprises: providing a probe with an immobilized capture ligand and containers for accommodating a liquid; enabling the probe and a first container to move relatively to capture an analyte in a solution in the first container; enabling the probe and a second container to move relatively to capture a detection ligand in a solution in the second container, wherein the detection ligand is directly or indirectly coupled with a light-emitting marker; and detecting an optical signal of the light-emitting marker in a probe reaction layer using an optical detection device, converting the optical signal into a digital signal, and counting the number of light-emitting markers based on the digital signal to determine a concentration of the analyte. The capture ligand binds to a first site of the analyte, and the detection ligand binds to a second site of the analyte.
Need to check novelty before this filing date? Find Prior Art

Description

A digital detection method

[0001] Cross-references

[0002] This application claims priority to Chinese application No. 202310501291.1 filed on May 6, 2023 and Chinese application No. 202410022779.0 filed on January 8, 2024, all of which are incorporated herein by reference in their entirety. Technical Field

[0003] This specification relates to the field of biological detection, and in particular to a digital quantitative detection method for biological molecules. Background Art

[0004] In biomedical research and testing, enzyme-linked immunosorbent assays (ELISAs) are currently widely used. The ELISA is based on the immobilization of an antigen or antibody and its enzyme labeling. Antigens or antibodies bound to the surface of a solid support retain their immunological activity, while enzyme-labeled antigens or antibodies retain both immunological and enzymatic activity. During the assay, the specimen (the antibody or antigen to be assayed) reacts with the antigen or antibody on the surface of the solid support. Washing is used to separate the antigen-antibody complex formed on the solid support from other substances in the solution. The enzyme-labeled antigen or antibody is then added and also binds to the solid support through the reaction. At this point, the amount of enzyme on the solid phase is proportional to the amount of the analyte in the specimen. Upon addition of the substrate for the enzyme reaction, the substrate is catalyzed by the enzyme to produce a colored product. The amount of the product is directly related to the amount of the analyte in the specimen, allowing qualitative or quantitative analysis based on the intensity of the color. In ELISA, the shapes of solid phase carriers mainly include microtiter plates, beads and small test tubes. During the reaction process, a certain amount of time is required to wait for the antibodies or antigens in the sample to be tested or the enzyme marker to diffuse to the surface of the solid phase carrier for reaction, which makes the detection time longer. The ELISA method includes many steps. It requires the sample to be tested to react, the solid phase carrier to be washed, and then the enzyme marker to be added for reaction. The operation is complicated and the detection time is longer. On the other hand, ELISA performs the final qualitative or quantitative analysis based on the color depth of the solution after the reaction, which makes the sensitivity of the test results relatively limited. Even if a fluorescent or chemiluminescent system with a non-enzymatic color development reaction is used, the sensitivity of the ELISA test results is still limited.

[0005] Therefore, the present application hopes to provide a digital quantitative detection method for biomolecules to shorten the detection time, improve the detection sensitivity, and expand the dynamic range of detection.

[0006] Summary of the Invention

[0007] One of the embodiments of the present specification provides a digital detection method, which includes: providing a probe with a fixed capture ligand and a container for containing a liquid; causing the probe to move relative to container one to capture the object to be detected in the solution in container one; causing the probe to move relative to container two to capture the detection ligand in the solution in container two, wherein the detection ligand is directly or indirectly coupled to a luminescent marker; detecting the optical signal of the luminescent marker in the probe reaction layer by an optical detection device, converting the optical signal into a digital signal, and counting the number of the luminescent markers based on the digital signal to determine the concentration of the object to be detected; wherein the capture ligand binds to the first site of the object to be detected, and the detection ligand binds to the second site of the object to be detected.

[0008] In some embodiments, the relative motion of the probe or the container includes one or more of up and down reciprocating motion, left and right reciprocating motion, and orbital motion according to a preset radius.

[0009] In some embodiments, the probe is in contact with the liquid in the container.

[0010] In some embodiments, the reaction layer for immobilizing the capture ligand is disposed on the bottom end surface or the bottom side surface of the probe in contact with the liquid in the container.

[0011] In some embodiments, the container 1 and the container 2 are different containers; and the relative movement between the probe and the container 2 occurs after the relative movement between the probe and the container 1.

[0012] In some embodiments, the container one and the container two are the same container; the object to be detected in the container one and the detection ligand in the container two are in a solution in the same container.

[0013] In some embodiments, after the relative movement of the probe and the container, a cleaning process is completed in a cleaning fluid in an additional container.

[0014] In some embodiments, the capture ligand comprises one or more of a compound, an antibody, an antigen, a protein, a cell, a virus, a bacterium, a nucleic acid, and a nucleic acid aptamer; and the detection ligand comprises one or more of a compound, an antibody, an antigen, a protein, a cell, a virus, a bacterium, a nucleic acid, and a nucleic acid aptamer.

[0015] In some embodiments, the capture ligand includes antibody 1, the detection ligand includes antibody 2, and the object to be detected includes an antigen; the antibody 1 and the antibody 2 can bind to different sites on the antigen.

[0016] In some embodiments, the probe is one or more.

[0017] In some embodiments, the number of the containers is one or more.

[0018] In some embodiments, the material of the probe to which the capture ligand is immobilized is a single component or multiple components of glass, quartz, plastic, rubber, ceramic, or metal.

[0019] In some embodiments, the optical signal is detected by the optical detection device while suppressing background signal by the luminescent marker.

[0020] In some embodiments, the luminescent marker is an upconverting luminescent nanoparticle.

[0021] In some embodiments, the particle size of the upconversion luminescent nanoparticles is 1 nm to 500 nm.

[0022] In some embodiments, when the density of the luminescent marker is within a preset range, the optical detection device counts the number of characteristic bright spots of the luminescent marker; when the density of the luminescent marker is outside the preset range, the optical detection device measures the overall luminous intensity of the luminescent marker to determine the concentration information of the object being detected. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] This specification will be further described in the form of exemplary embodiments, which will be described in detail with reference to the accompanying drawings. These embodiments are not limiting, and in these embodiments, like numbers represent like structures, wherein:

[0024] FIG1 is an exemplary flow chart of a detection method according to some embodiments of the present specification;

[0025] FIG2 is a schematic diagram of biomolecule binding according to the detection method shown in some embodiments of this specification;

[0026] FIG3 is an exemplary block diagram of a detection device according to some embodiments of this specification;

[0027] FIG4 is an exemplary schematic diagram of a detection device according to some embodiments of this specification;

[0028] FIG5 is an exemplary schematic diagram of a probe and a container according to some embodiments of the present specification;

[0029] FIG6 is an exemplary schematic diagram of a probe and a container according to some embodiments of the present specification;

[0030] FIG7 is an optical image of different concentrations of detected substances in a first set of experiments according to some embodiments of this specification;

[0031] FIG8 is an optical image of a second set of experiments at different concentrations of a detected substance according to some embodiments of this specification;

[0032] FIG. 9 shows imaging images of quantum dots and upconversion luminescent nanoparticles at different exposure times according to some embodiments of the present specification. DETAILED DESCRIPTION

[0033] To more clearly illustrate the technical solutions of the embodiments of this specification, the following briefly describes the drawings required for describing the embodiments. Obviously, the drawings described below are merely examples or embodiments of this specification. Those skilled in the art can apply this specification to other similar scenarios based on these drawings without inventive effort. Unless otherwise apparent from the context or otherwise noted, the same reference numerals in the figures represent the same structure or operation.

[0034] It should be understood that the terms "system," "device," "unit," and / or "module" used herein are a method for distinguishing different components, elements, parts, portions, or assemblies at different levels. However, if other terms can achieve the same purpose, the terms may be replaced by other expressions.

[0035] Unless the context clearly indicates otherwise, the words "a," "an," "an," and / or "the" do not refer to the singular but include the plural. Generally speaking, the terms "include" and "comprise" only indicate the inclusion of the steps and elements specifically identified, and these steps and elements do not constitute an exclusive list. A method or apparatus may also include other steps or elements.

[0036] Flowcharts are used throughout this specification to illustrate the operations performed by systems according to embodiments of this specification. It should be understood that preceding or following operations do not necessarily need to be performed in exact order. Instead, the steps may be processed in reverse order or simultaneously. Furthermore, other operations may be added to these processes, or one or more operations may be removed from these processes.

[0037] In the field of biomedical testing, the ELISA detection method and detection device have the problems of long detection time and low detection sensitivity. During the reaction process on the surface of the solid phase carrier (microtiter plate, beads and small test tube) in the detection device, a long time is needed to wait for the antigen or antibody in the solution to fully diffuse to the surface of the solid phase carrier for reaction, which makes the detection time longer. In addition, the detection method of reaction (test specimen reaction)-washing (washing solid phase carrier)-reaction (adding enzyme marker for reaction) has complicated operation steps, among which the washing step requires more time and manpower to meet the washing standard. Moreover, the final test result is a qualitative or quantitative analysis based on the depth of the color of the solution after the reaction, and the sensitivity of the test result also has room for improvement. In some embodiments, in order to solve the time and manpower problems in the above-mentioned washing step, an automatic plate washer is used to clean the solid phase carrier, but the other above-mentioned problems still exist.

[0038] Some embodiments of the present specification provide a new digital quantitative detection method for biological molecules and a corresponding detection device capable of executing the detection method. On the one hand, the detection method improves the sensitivity of the detection result by counting single molecules or single particles. On the other hand, by setting the probe as a solid phase carrier and the reaction layer as the bottom end face or bottom side face of the probe in contact with the liquid in the container, the relative movement between the probe and the container allows the reactants in the solution to diffuse to the reaction layer more quickly, thereby increasing the reaction binding rate and shortening the detection time. Furthermore, the present application can also realize the automation or intelligent control of biological reactions by automatically controlling the movement speed and movement form of the probe and several containers, further saving operation time and operating manpower. In some embodiments, the biological detection method in the present application includes providing a probe with a capture ligand, and the capture ligand is fixed to the reaction layer of the probe; then the probe and the container are moved relative to each other so that the capture ligand on the reaction layer binds to the object to be detected in the container, and then the probe and another container are moved relative to each other so that the object to be detected on the reaction layer binds to the detection ligand in the solution in the other container, and the detection ligand is directly or indirectly coupled to the luminescent marker, and finally the number of markers on the reaction layer can be counted or the overall luminescence intensity of the marker can be measured by an optical detection device, and the concentration of the object to be detected in the solution can be determined. In some embodiments, the detection method and detection device in the present application can be applied to the detection of any biomarker, as long as the marker has a capture ligand and a detection ligand that can correspond to the capture ligand and the detection ligand in the present application, that is, the capture ligand and the detection ligand can bind to different sites of the object to be detected, and the detection ligand can be coupled to the luminescent marker, so that the concentration information of the object to be detected can be determined by the number of luminescent markers. Any reaction of the probe reaction layer with the solution in the container in this application (including but not limited to binding, capture, activation, coupling, blocking, amplification, etc.) may be accompanied by a cleaning process in the cleaning solution in the additional container immediately after the reaction. For convenience, it will not be described in detail below. The ligands in this application include but are not limited to compounds, antibodies, antigens, proteins, cells, viruses, bacteria, nucleic acids, and nucleic acid aptamers. For convenience, the following description will be given using antibodies as capture ligands and antigens as the detected objects.

[0039] FIG1 is an exemplary flow chart of a detection method according to some embodiments of the present disclosure. As shown in FIG1 , process 100 includes steps 110 , 120 , 130 , and 140 .

[0040] Step 110 , providing a probe having a capture ligand fixed thereon and a container for containing a liquid.

[0041] In some embodiments, the capture ligand can be an antibody, the analyte can be an antigen, and the detection ligand is also an antibody. To distinguish, in this embodiment, the capture ligand can be antibody 1 and the detection ligand can be antibody 2. The probe serves as a solid-phase carrier for binding to the capture ligand. The capture ligand immobilized on the reaction layer remains active and can react with the corresponding analyte.

[0042] In some embodiments, the capture ligand can be fixed on the reaction layer before detection. For example, a commercial probe with a capture ligand pre-fixed is provided. In order to maintain the activity of the capture ligand, a protective layer is added to the reaction layer of the commercial probe. Correspondingly, in some embodiments, at the beginning of the detection, the probe needs to be placed in a container filled with a cleaning solution to remove the protective layer (and impurities) on the capture ligand on the reaction layer. In some embodiments, the steps of this embodiment can control the relative movement of the probe and the container to achieve rapid removal of the protective layer and impurities on the reaction layer.

[0043] In some embodiments, the capture ligand can be fixed on the reaction layer during the detection process. In some embodiments, the process of fixing the capture ligand on the reaction layer can include: immersing the reaction layer of the probe in solution one for a first preset time to activate the reaction layer of the probe; immersing the activated reaction layer of the probe in solution two for a second preset time to achieve coupling between the capture ligand and the probe; immersing the coupled probe in solution three for a third preset time to achieve sealing of the activated reaction layer. The reaction layer of the probe in one or more embodiments of this specification refers to the part of the probe surface that can bind to the biological molecules involved in the reaction. In some embodiments, when the capture ligand is an antibody, solution one for activation can be 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC) / N-hydroxysuccinimide (NHS); solution two for coupling can be the capture antibody; solution three for blocking can be 0.05%-0.5% bovine serum albumin or 10% calf serum or 1% gelatin. Correspondingly, the first preset time may be 1 to 60 minutes; the second preset time may be 1 to 60 minutes; and the third preset time may be 5 to 120 minutes. In some embodiments, the first preset time, the second preset time, and the third preset time may be selected based on actual needs, for example, the time may be selected from 1 hour to 24 hours.

[0044] In some embodiments, the probe moves in the cleaning solution in the container to clean the protective layer, or the probe is immersed in the three solutions to activate, couple, and block the antibody, which can be performed using the detection device 400 shown in Figure 4. For more description, please refer to other parts of this specification.

[0045] In some embodiments, the number of containers can be one or more. In some embodiments, one container can be included. In some embodiments, two containers can be included, such as container one and container two. In some embodiments, three or more containers can be included.

[0046] Step 120 , making the probe and the container one move relative to each other to capture the object to be detected in the solution in the container one.

[0047] In some embodiments, container 1 contains a test solution containing a test substance (e.g., an antigen). After a capture ligand (e.g., antibody 1) is immobilized on the reaction layer, the probe and container 1 can be moved relative to each other to capture the test substance in the solution in container 1. After the capture ligand is immobilized on the reaction layer, the probe and container 1 can be moved relative to each other to allow the capture ligand on the probe reaction layer to bind to the test substance in container 1.

[0048] In some embodiments, this step can be performed by the detection device shown in Figure 4. As shown in Figure 4, the detection device 400 includes a probe assembly 410 and a vibration platform 420. The probe assembly 410 includes a probe seat 411 and a probe 412. The probe seat 411 is used to mount multiple probes 412. The vibration platform 420 is used to place a number of containers or a container assembly 421 that integrates multiple containers. In some embodiments, the container can be placed directly on the vibration platform 420. As an example only, the container can be placed in a hole, recess or positioning groove of the vibration platform 420. In some embodiments, the container assembly 421 integrates multiple containers, and the container assembly 421 is placed on the vibration platform 420. In some embodiments, the relative movement between the probe 412 and the container one (not shown in Figure 4) can be achieved by the operator manually shaking the probe 412. In some embodiments, the relative movement between the probe 412 and the container one can also be achieved by driving the movement of the probe 412 and / or the container one by a drive assembly. For more description of the automatically controlled detection device, please refer to other parts of this specification.

[0049] In some embodiments, the relative motion of the probe and the container includes one or more of up and down reciprocating, left and right reciprocating, and orbital motion according to a preset radius. In some embodiments, the relative motion between the probe and container one may include a mode in which the probe moves while the container one does not move; a mode in which the probe does not move while the container one moves; or a mode in which both the probe and the container move. In some embodiments, the motion of the probe 412 and / or container one may include linear reciprocating motion or rotational motion. In some embodiments, the direction of the linear reciprocating motion includes reciprocating motion in the up and down direction (see the Z direction in FIG. 4 ), reciprocating motion in the left and right direction (see the X direction in FIG. 4 ), reciprocating motion in the front and back direction (see the Y direction in FIG. 4 ), and reciprocating motion along other preset directions. In some embodiments, rotational motion is a mode in which orbital motion is performed according to a preset radius. In some embodiments, the probe 412 and / or container one may adopt at least one of the above-mentioned motion modes. In some embodiments, the probe 412 and / or container one may also adopt other motion modes, such as a circular motion with a triangular motion trajectory or a reciprocating motion mode.

[0050] In some embodiments, the probe contacts the liquid in the container. The motion pattern of the probe and container 1 can also be determined based on the contact pattern between the probe and the liquid in container 1. In some embodiments, the probe can contact the liquid by immersion, meaning the reactive layer of the probe must be immersed in the liquid. As an example, referring to the embodiment shown in FIG5 , during the detection process, the reactive layer of probe 512 must be immersed in the liquid in container 526. In some embodiments, the probe can contact the liquid by point contact or surface contact, meaning the reactive layer of the probe barely contacts the surface of the liquid. As an example, referring to the embodiment shown in FIG6 , the bottom surface of probe 612 contacts the liquid droplet on the surface of container 626 by point contact or surface contact. In some embodiments, when the probe is in immersion contact with the liquid in container 1, one of the probe and container 1 performs rotational motion, while the other performs up and down reciprocating motion. For example, the probe rotates while container 1 performs up and down reciprocating motion. In some embodiments, the probe can also perform both rotational motion and up and down reciprocating motion simultaneously. This relative motion mode can make the probe stir in the liquid in a spiral ascending / descending shape, which can make the reactants in the solution diffuse to the reaction layer more quickly, so as to react more quickly and fully with the ligands on the reaction layer, thereby improving the detection speed and saving detection time. In some embodiments, the probe and one of the containers make circular motions, and the other makes reciprocating motions in the horizontal plane, for example, left and right reciprocating motions. In some embodiments, when the probe is in point contact or surface contact with the liquid in container one, the probe and at least one of container one make circular motions or linear reciprocating motions. Among them, linear reciprocating motion includes left and right reciprocating motion or back and forth reciprocating motion. For example, container one remains stationary, and the probe makes circular motions or makes linear reciprocating motions in the left and right directions. For example, the probe does not move, and container one makes circular motions or makes linear reciprocating motions in the front and back directions.

[0051] In some embodiments, the number of probes is one or more. In some embodiments, a plurality of probes are arranged in a row, such as the eight probes 412 in FIG4 . In some embodiments, the probe is columnar, i.e., the cross-sectional dimensions of the probe at different positions along the axial direction are the same. The shape of the cross-section of the columnar probe includes, but is not limited to, circular, elliptical, rectangular, or polygonal. In some embodiments, the cross-sectional dimensions of the probe at different positions along the axial direction may also be different, such as the shape of the probe being conical or truncated cone. In some embodiments, the reaction layer for fixing the capture ligand may be provided on the bottom end face or bottom side face of the probe in contact with the liquid in the container. The bottom face of the probe in one or more embodiments of this specification is the portion in contact with the liquid in the container, and in contrast, the top face of the probe is the portion connected to the probe seat. As an example, as shown in FIG5 , the reaction layer on the bottom face of the probe 512 may be provided on the bottom end face of the probe 512, or on the circumferential side face of the bottom face of the probe 512. As shown in FIG6 , the reaction layer on the probe 612 needs to be provided on the bottom end face of the probe 612.

[0052] In some embodiments, the material of the probe to which the capture ligand is immobilized is a single component or multiple components selected from glass, quartz, plastic, ceramic, or metal. In some embodiments, the material of the probe can be a single component. For example, the probe can be a polymer probe (such as polystyrene (PS), polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), etc.), a glass probe, or a quartz probe.

[0053] Step 130 , the probe and container 2 are moved relative to each other to capture the detection ligand in the solution in container 2; the detection ligand is directly or indirectly coupled to the luminescent marker.

[0054] In some embodiments, the solution contained in container two contains a detection ligand (e.g., antibody two). After the reaction layer binds to the object to be detected (e.g., antigen), the probe and container two can be moved relative to each other to capture the detection ligand (e.g., antibody two) in the solution in container two. The capture of the detection ligand can be achieved by the object to be detected, that is, the capture ligand on the reaction layer binds to the object to be detected, and then the object to be detected binds to the detection ligand, thereby obtaining a capture ligand and a detection ligand bound to different sites of the object to be detected. In some embodiments, the capture ligand includes antibody one, the detection ligand includes antibody two, and the object to be detected includes an antigen; antibody one and antibody two can bind to different sites of the antigen, that is, the capture ligand (e.g., antibody one) binds to the first site of the object to be detected (e.g., antigen), and the detection ligand (e.g., antibody two) binds to the second site of the object to be detected (e.g., antigen). The detection ligand is directly or indirectly coupled to a luminescent marker, and a single molecule of the object to be detected and its capture ligand and detection ligand bound at different sites form a whole, which can be reflected by the luminescent marker coupled to the detection ligand. As an example, as shown in Figure 2, the object to be detected is an antigen, the capture ligand is antibody 1, and the detection ligand is antibody 2. Antibody 1 is fixed to the reaction layer of probe 212, and antibody 2 is coupled to the upconversion luminescent nanoparticle. Antibody 1 binds to the first site A of the antigen, and antibody 2 binds to the second site B of the antigen. Therefore, based on the single-molecule operation of the object to be detected, each single molecule will bind to a capture ligand and a detection ligand, and the detection ligand is coupled to a marker molecule. On this theoretical basis, the number of molecules of the object to be detected can be calculated by the number of marker molecules. In some embodiments, the number of markers and detection ligands is a one-to-one relationship, that is, one detection ligand is coupled to a marker. In some embodiments, the number of markers and detection ligands can also be a one-to-N relationship. In some embodiments, the number of markers and detection ligands can also be an N-to-one relationship. The value of N can range from 1 to 5, for example, 1, 2, 3, 4, 5. In some embodiments, the value of N can also be greater than 5. The value of N is related to the type of marker and the type of coupling.

[0055] In some embodiments, the luminescent marker coupled to the detection ligand may include direct binding or indirect binding. The direct binding refers to the direct coupling of the detection ligand to the luminescent marker by physical adsorption or chemical modification. The indirect binding refers to the indirect coupling of the luminescent marker to the detection ligand through an anti-detection ligand (such as a secondary antibody) or a biotin-streptavidin system or other reaction system. The detection ligand can be coupled to the marker in advance before the detection begins, and the solution of the detection ligand coupled to the marker can be placed in container two. It is also possible to capture the detection ligand first and then indirectly capture the marker during the detection process. In this case, the detection ligand can be placed in container two and the luminescent marker can be placed in container three. The probe reaction layer combined with the detection ligand can be prepared for coupling with the luminescent marker by reacting with the solution in other additional containers before reacting with the luminescent marker in container three. In some embodiments, the relative movement between the probe and container two (or container three / extra container) in this step can be carried out by the detection device shown in Figure 4. For the description of the movement of the probe and the second container (or the third container / the additional container), reference may be made to the description of the probe and the first container.

[0056] In some embodiments, a luminescent marker refers to a material particle that can emit a light signal (or luminescent signal, optical signal). The luminescent signal can be captured by an optical detection device, so that the luminescent marker can be identified. In some embodiments, the luminescent signal includes but is not limited to fluorescence, phosphorescence, or other luminescent signals. In some embodiments, the luminescent signal of the luminescent marker is emitted by induction (or excitation). In some embodiments, the luminescent marker may include one or more organic / inorganic luminescent materials such as fluorescent / phosphorescent dye molecules, rare earth elements, rare earth chelates, fluorescent proteins, and luminescent nanoparticles synthesized based on luminescent materials. Luminescent nanoparticles include: quantum dots, rare earth chelate nanoparticles, up-conversion luminescent nanoparticles, time-resolved fluorescent microspheres, etc. In some embodiments, the particle size of the luminescent nanoparticles is 1nm to 500nm. For example, the particle size of the luminescent nanoparticles can be about 1 nm, 10 nm, 20 nm, 30 nm, 40 nm, 50 nm, 60 nm, 70 nm, 80 nm, 90 nm, 100 nm, 120 nm, 140 nm, 160 nm, 180 nm, 200 nm, 250 nm, 300 nm, 350 nm, 400 nm, 450 nm, or 500 nm. In some embodiments, the particle size of the luminescent nanoparticles is between 10 nm and 500 nm. In some embodiments, the particle size of the luminescent nanoparticles is between 50 nm and 400 nm. In some embodiments, the particle size of the luminescent nanoparticles is between 100 nm and 300 nm. In some embodiments, the particle size of the luminescent nanoparticles is between 20 nm and 200 nm. In some embodiments, the particle size of the luminescent nanoparticles is between 100 nm and 200 nm. Wherein, the particle size can be understood as the distance between the two farthest points on the surface of the particle.

[0057] In some embodiments, the specific optical signal emitted (e.g., induced to emit) by the luminescent marker has a relative separability from the background that meets predetermined conditions, so that the optical detection device can suppress part of the background signal. Or the luminescence mechanism of the luminescent marker itself suppresses the occurrence of part of the background fluorescence signal. The background signal refers to the non-specific optical signal detected by the optical detection device. For example, the background signal may include the autofluorescence of the luminescent marker, the detected object and / or other substances (e.g., cells, tissues, impurities, etc.) in the sample, and the autofluorescence of the substrate (e.g., probe) itself. The relative separation refers to the degree of difference or separation between the signal and the background. In some preferred embodiments, the luminescent marker is an up-conversion luminescent nanoparticle or a time-resolved fluorescent microsphere. In some embodiments, for the first background signals of different intensities brought by different substrates, the relative separability between the specific optical signal emitted by the up-conversion luminescent nanoparticle or the time-resolved fluorescent microsphere and the background makes it possible to separate or substantially separate the specific optical signal from the first background signal by conventional optical elements (e.g., apertures and filters, etc.). For example, depending on the probe material, the first background signal can be derived from the autofluorescence of a high molecular polymer probe (e.g., PDMS, PMMA, PS, etc.) with a higher signal intensity, or from the autofluorescence of a glass probe or a quartz probe with a lower signal intensity. In some preferred embodiments, the luminescent marker is an upconversion luminescent nanoparticle.

[0058] Step 120 and step 130 can be performed in the same container or in different containers. When step 120 and step 130 are performed in different containers, that is, container 1 and container 2 are two different containers, step 130 needs to be performed after step 120. Even if the probe and container 2 are in relative motion, step 130 occurs after the probe and container 1 are in relative motion. Specifically, the probe needs to move relative to container 1 to capture the analyte in container 1 before it can move relative to container 2 to allow the analyte on the reaction layer to bind to the detection ligand in container 2. When step 120 and step 130 are performed in the same container, that is, container 1 and container 2 are the same container, step 120 and step 130 can be performed together or combined into one step, that is, the analyte in container 1 and the detection ligand in container 2 are pre-mixed in a solution in the same container. Specifically, the detection ligand in container 1 is pre-bound to the second site of the analyte to form a complex, and the probe is moved relative to container 1 to allow the capture ligand on the reaction layer to bind to the first site of the analyte on the complex in container 1.

[0059] Step 140 : Detect the optical signal of the luminescent marker of the probe reaction layer by an optical detection device, convert the optical signal into a digital signal, and count the number of luminescent markers based on the digital signal to determine the concentration of the detected object.

[0060] After the capture ligand, the object to be detected, the detection ligand and the luminescent marker are combined into a whole, there is a certain linear relationship between the number of luminescent markers and the concentration of the object to be detected. At this time, the number of luminescent markers in the probe reaction layer can be counted by an optical detection device to determine the concentration of the object to be detected. In some embodiments, since the luminescent marker is a molecule or particle that can emit a light signal (such as a fluorescent signal), the optical detection device identifies the luminescent marker through the light signal. The optical detection device detects the number of characteristic bright spots on the reaction layer to determine the number of luminescent markers. In some embodiments, the statistics on the number of luminescent markers can be understood as statistics on the number of luminescent signals emitted by the luminescent markers. It should be noted that the statistics on the number of luminescent markers in this application are not direct statistics on the molar number or molar concentration of the luminescent marker, but statistics on the number at the single molecule or single particle level.

[0061] In some embodiments, the digital signal includes an optical image (or digital image signal). In some embodiments, an optical image of the probe reaction layer can be obtained by an optical detection device. As an example, the optical image in Figure 7 or 8 can be referred to. The image background of the optical image is black, and the characteristic bright spots displayed are upconversion luminescent nanoparticles. The number of characteristic bright spots in the optical image is the number of luminescent markers, which can be used to determine the concentration of the detected object.

[0062] In some embodiments, after acquiring the optical image, the optical detection device can determine the number of characteristic bright spots in the optical image by having the operator count them. Alternatively, an image recognition algorithm can be used instead of the operator counting method, i.e., using a single particle counting method to identify the number of characteristic bright spots in the image, thereby determining the number of luminescent markers on the reaction layer. In some embodiments, after acquiring the optical image, the optical detection device can also analyze the optical image using a grayscale averaging method. The grayscale averaging method primarily uses a weighted average, arithmetic mean, or other average value of the grayscale of pixels per unit image area to determine the overall luminescence intensity of the luminescent markers in the image, thereby determining the concentration of the detected object. In some embodiments, to further improve the linear range of the detection results, two image processing algorithms can be pre-set in the optical detection device: a first processing algorithm is a single particle counting method, and a second processing algorithm is a grayscale averaging method. When the density of the luminescent marker is below a preset threshold or within a preset range, the optical detection device counts the number of characteristic bright spots of the luminescent marker, i.e., uses the first processing algorithm. When the density of the luminescent marker is above the preset threshold or outside the preset range, the optical detection device measures the overall luminescence intensity of the luminescent marker to determine the concentration information of the detected object, i.e., uses the second processing algorithm.

[0063] In some embodiments, the first processing algorithm includes step a1, identifying pixels whose brightness exceeds a preset threshold based on the optical image. For example, the preset threshold can be set based on the overall brightness of the optical image (or background brightness). Brightness identification can be used to delineate the optical image into areas corresponding to the characteristic bright spots of the luminescent marker and areas corresponding to the background.

[0064] In some embodiments, the first processing algorithm further comprises step a2, determining the number of characteristic bright spots of the luminescent marker by determining the number of signal peaks based on the recognition result of the pixel point. Wherein, a signal peak refers to a signal value (e.g., brightness value) of a local pixel (or local area) on the image that is prominent relative to the surrounding pixels (or surrounding area). In some embodiments, a signal peak is a local pixel and adjacent area in the area corresponding to the characteristic bright spot of the luminescent marker with a brightness higher than that of the surrounding pixels. It is understandable that the signal peak can be used to reflect the characteristic bright spot of the luminescent marker. The first processing algorithm can identify independent characteristic bright spots that are essentially non-overlapping / connected based on a single signal peak, or it can identify multiple characteristic bright spots that are partially overlapped / connected in the same characteristic area due to a close distance through a single signal peak. In some embodiments, the characteristic bright spot can also be the position of the luminous center point in the signal peak area inferred from the image by the algorithm, especially when the algorithm identifies two or more characteristic bright spots in one signal peak. The number of signal peaks in the optical image can reflect the number of characteristic bright spots of the luminescent marker, thereby determining the concentration information of the detected object.

[0065] In some embodiments, before step a1, the first processing algorithm further includes step a0 of performing noise reduction preprocessing on the optical image. It is understood that noise reduction preprocessing can reduce possible background noise (or background signal) interference and improve the accuracy of the characteristic bright spot statistics of the luminescent marker.

[0066] In some embodiments, the optical signal is detected by the optical detection device when the background signal is suppressed by the luminescent marker. The optical signal of the luminescent marker on the probe reaction layer is transmitted to the photosensitive element through the optical path of the optical detection device, and the optical signal is collected by the photosensitive element and converted into a digital signal (for example, an optical image). The optical detection device of some embodiments of this specification suppresses the occurrence of some background signals during the detection process by the luminescent marker, wherein the relative separation between the specific optical signal emitted by the luminescent marker and the background makes the optical detection device have no requirements for assisting in improving the imaging resolution of the optical path system, and without the need for amplification of the object to be detected and / or amplification of the photoelectric signal, the optical image output by the photosensitive element can meet the quality requirements of the number of luminescent markers through image recognition.

[0067] In some embodiments, this specification also provides a detection device that can perform the detection methods described in one or more of the above embodiments. Figure 3 is an exemplary module block diagram of a detection device shown in some embodiments of this specification. As shown in Figure 3, the detection device 300 includes a probe assembly 310, a vibration platform 320, a probe drive assembly 330 for driving the probe assembly 310, a platform drive assembly 340 for driving the vibration platform 320, and a control assembly 360 that is signal-connected to the probe drive assembly 330 and the platform drive assembly 340. The control assembly 360 can control the movement of the probe assembly 310 through the probe drive assembly 330, and can also control the movement of the vibration platform 320 through the platform drive assembly 340. In some embodiments, the detection device 300 also includes an optical detection device 350 for detecting the reaction layer of the probe. In some embodiments, the control assembly 360 can also be signal-connected to the optical detection device 350 to control the optical detection device 350 to perform optical detection on the reaction layer of the probe to determine the number of luminescent markers on the reaction layer of the probe or the overall luminescent intensity of the luminescent markers, thereby determining the concentration of the analyte in the solution being detected.

[0068] In some embodiments, the optical detection device 350 may include a first optical detection device and a second optical detection device. The first optical detection device corresponds to the single particle counting method for detection and analysis, while the second optical detection device corresponds to the grayscale averaging method for detection and analysis. When the density of the luminescent marker is within a preset range, the control component 360 automatically selects the first optical detection device for detection; when the density of the luminescent marker exceeds the preset range, the control component 360 automatically selects the second optical detection device for detection. In some embodiments, the first and second optical detection devices may correspond to the same hardware device.

[0069] In some embodiments, the optical detection device 450 includes an optical path and a photosensitive element.

[0070] The optical path is used to focus light onto the photosensitive element. In some embodiments, the optical path may be a non-high-resolution imaging optical path. A high-resolution imaging optical path refers to an optical path configuration that significantly improves imaging resolution and / or suppresses background light. For example, using a high-magnification, high-numerical-aperture objective lens can achieve high-resolution imaging; a laser confocal scanning microscope uses an optical path system to perform point scanning and laser focusing, thereby achieving or assisting in achieving low-background, high-resolution imaging; or a total internal reflection microscope uses an optical path system to achieve or assist in achieving low-background imaging by utilizing total internal reflection. Low background refers to a background signal that is significantly lower than the optical signal of the luminescent marker. Correspondingly, a non-high-resolution imaging optical path refers to an optical path configuration that does not significantly improve imaging resolution and does not significantly suppress background light. For example, in addition to conventional optical elements (such as filters and apertures), the non-high-resolution imaging optical path does not employ other measures that can significantly suppress background light. In some embodiments, the optical path includes an objective lens 451, a light source 452, and a tube lens 453.

[0071] In other embodiments, the optical path may be an optical path for high-resolution imaging.

[0072] The photosensitive element 454 is used to collect optical signals and convert them into digital signals (eg, optical images). In some embodiments, the photosensitive element 454 may be a CMOS, a CCD, a silicon photomultiplier (SiPM), or the like.

[0073] In some embodiments, optical inspection device 450 further includes an imaging tank 455. Imaging tank 455 is used for holding objects and / or for imaging. For example, imaging tank 455 can contain an imaging fluid, allowing probe 412 to be immersed in the imaging fluid for imaging. Exemplarily, as shown in FIG4 , optical inspection device 450 includes an objective lens 451, a light source 452, a tube lens 453, a photosensitive element 454, and imaging tank 455.

[0074] In addition to the above-mentioned hardware devices, the optical detection device 350 may also include an image processor, which is preset with a first processing algorithm and a second processing algorithm. The first processing algorithm corresponds to the single particle counting method, and the second processing algorithm corresponds to the grayscale averaging method. When the density of the luminescent marker exceeds the preset range, the control component 360 can select the second processing algorithm for image processing, and when the density of the luminescent marker is within the preset range, the control component 360 can select the first processing algorithm for image processing. Among them, when the detection operation of the detected solution begins, it can be roughly judged whether the density of the luminescent marker exceeds the preset range. In some embodiments, when the control component 360 controls the optical detection device 350 to detect the reaction layer of the probe at the beginning stage, the optical detection device 350 can be used to judge the density of the luminescent marker on the current reaction layer. If the density is large, the second optical detection device or the second processing algorithm is selected for processing. If the density is not large, the first optical detection device or the first processing algorithm is selected for processing.

[0075] In some embodiments, the probe assembly 310 includes a plurality of movable probe seats, each of which is provided with a plurality of probes spaced apart. The vibration platform 320 is used to place a plurality of containers or a container assembly incorporating a plurality of containers. The plurality of containers are positioned correspondingly to the plurality of probes. The spacing between two adjacent containers is consistent or substantially consistent with the spacing between two adjacent probes.

[0076] Fig. 4 is the exemplary schematic diagram of the detection device shown in some embodiments of this specification.As shown in Figure 4, detection device 400 comprises probe assembly 410, vibration platform 420 and optical detection equipment 450.Probe assembly 400 comprises probe seat 411 and several probes 412 fixed on probe seat 411.Probe 412 can be detachably fixedly set with probe seat 411, also can be non-detachably fixedly set.The material of probe 412 and probe seat 411 can be the same, also can be different.In certain embodiments, probe assembly 410 can comprise multiple probe seats 411, and each probe seat is all fixed with multiple probes 412, and the number of probes 412 and the number of containers placed on vibration platform 420 have corresponding relationship.

[0077] In some embodiments, the control component can also automatically determine the movement sequence of probe 412, as well as the movement mode and speed of probe 412 and vibrating platform 420, based on the type of biological detection operation being performed, thereby controlling the movement mode and speed of the container or container assembly 421 on the vibrating platform. The movement mode and speed of vibrating platform 420 are consistent with the movement mode and speed of the container or container assembly 421 on it. For example, the control component can determine the movement trajectory of probe 412 based on the type of biological detection operation being performed, first moving it in container one for a certain period of time, then moving it in container two for a certain period of time, and finally moving it in container three for a certain period of time. The probe assembly 410 is then moved to the optical detection device 450, causing the objective lens 451 in the optical detection device 450 to image the reaction layer of probe 412, or to image the reaction layer of probe 412 immersed in the imaging solution of the imaging tank through the bottom of the imaging tank, thereby obtaining an optical image with multiple characteristic bright spots of luminescent markers. After obtaining the optical image, the control component automatically selects a corresponding image processing algorithm to process the image to obtain the number of luminescent markers in the image, thereby determining the concentration of the detected object.

[0078] In order to reflect the technical effects of some embodiments of this specification, quantum dots and upconversion luminescent nanoparticles are selected as luminescent markers for imaging experiments in this specification. After the luminescent marker is diluted by a predetermined multiple (100,000 times), a predetermined amount (for example, 0.5 μL) is dropped on the surface of the PMMA plate substrate, and the corresponding excitation light is used to induce the luminescent marker to emit a light signal. After drying, optical images are collected under different exposure times (100ms, 630ms and 1000ms). The experimental results show that in the image with an exposure time of 100ms, the characteristic bright spots displayed by the quantum dots are low in brightness and small in number (see part A of Figure 9). In the image with an exposure time of 630ms, the number of characteristic bright spots displayed by the quantum dots increases (see part B of Figure 9). However, when the PMMA substrate is excited to produce a strong background fluorescence signal, the difficulty of distinguishing a single characteristic bright spot increases. In the image with an exposure time of 1000ms, the characteristic bright spots displayed by the quantum dots are submerged in the background fluorescence signal excited by the PMMA substrate, and the difficulty of distinguishing a single characteristic bright spot is further increased (see part C of Figure 9). It can be seen that the longer the exposure time, the higher the characteristic bright spot brightness that quantum dots show, but the background signal interference is also more obvious. And under the same experimental conditions, the up-conversion luminescent nanoparticles all show good background signal suppression effect on the images of different exposure times, particularly under long exposure time. On the image with an exposure time of 1000ms, the up-conversion luminescent nanoparticles show characteristic bright spots with clear boundaries, and the background fluorescence signal that the PMMA substrate is excited is fully separated / suppressed (see part D of Figure 9). It is understandable that the up-conversion luminescent nanoparticles have better applicability in the digital detection method applied to the present specification embodiments.

[0079] In order to further reflect the technical effects of some embodiments of this specification, this specification provides two sets of experimental data. The experimental conditions are: the probe uses a surface carboxyl-coated glass probe with a diameter of 1 mm, and the container assembly (here is a 96-well plate) is placed on a vibration platform (Big Bear Automation HT-91100). The typical volume of a single well of a 96-well plate is 180 μL. The relative motion of the probe and the container during the detection process is: in all reaction steps and cleaning steps, the vibration platform performs circular motion at a rotation speed of 1000 rpm, and the diameter of the circular motion is 1 mm. The experiment was carried out in a temperature-controlled environment at 37°C. The antibody used in the experiment is anti-new coronavirus N protein antibody 1 (Novizan RM3143-00), and the antibody 2 is anti-new coronavirus N protein antibody 2 (Novizan RM3161-00). The object to be detected is the new coronavirus N protein (Feipeng ncov-PS-Ag6), and the luminescent marker is up-conversion luminescent nanoparticles (self-made). The particle size used in the first group of experiments is 100 nm. The probe reaction sequence in the first set of experiments is as follows. After each reaction step, it is necessary to wash with PBST buffer (added with 0.05% Tween-20):

[0080] 1. Dilute EDC and NHS to 100 μg / μL in 50 mM MES buffer, add the probe and react for 30 minutes;

[0081] 2. Dilute the antibody to 20 μg / mL in 50 mM MES buffer and add the probe to react for 30 minutes;

[0082] 3. Add the probe to 2% ethanolamine solution (add 0.5% BSA) and react for 2 hours;

[0083] 4. Dilute the analyte at five different concentrations in PBS buffer (with 0.5% BSA) and add the probe to react for 1 hour;

[0084] 5. Dilute the biotinylated antibody to 10 μg / mL in PBST buffer (add 0.5% BSA) and add the probe to react for 1 hour;

[0085] 6. Dilute the streptavidin-labeled upconversion luminescent nanoparticles to 10 μg / mL in 20 mM Tris buffer (added with 1% BSA and 0.05% Tween-20), add the probe and react for 30 minutes.

[0086] After the above steps are completed, an optical detection device is used to obtain an optical image of the probe reaction layer, see AE in Figure 7, which correspond to five different concentrations of the SARS-CoV-2 N protein: 0 ng / mL (corresponding to Figure A in Figure 7), 0.01 ng / mL (corresponding to Figure B in Figure 7), 0.1 ng / mL (corresponding to Figure C in Figure 7), 1 ng / mL (corresponding to Figure D in Figure 7) and 10 ng / mL (corresponding to Figure E in Figure 7).

[0087] Compared with the first set of experiments, the second set of experiments changed the particle size of the upconversion luminescent nanoparticles in the first set of experimental conditions from 100nm to 200nm, and the specific solution concentration or solution name in each step was slightly different. The other experimental conditions and probe reaction sequence were basically the same as the first set.

[0088] 1. Dilute EDC and NHS to 100 μg / uL in 50 mM MES buffer, add the probe and react for 30 minutes;

[0089] 2. Dilute the antibody to 20 μg / mL in a mixture of 50 mM MES and 20 mM NaAc-HAC buffer and add the probe to react for 30 minutes;

[0090] 3. 2% ethanolamine solution (with 0.5% BSA added), add the probe and react at 4°C for 2 hours;

[0091] 4. Dilute the analyte at five different concentrations in 0.5% Triton X-100 buffer (with 2.5% NaCl and 0.5% BSA) and add the probe for 1 hour.

[0092] 5. Dilute the biotinylated antibody to 10 μg / mL in PBST buffer (add 0.5% BSA) and add the probe to react for 1 hour;

[0093] 6. Dilute the streptavidin-labeled upconversion luminescent nanoparticles to 10 μg / mL in 20 mM Tris buffer (added with 1% BSA and 0.05% Tween-20), add the probe and react for 30 minutes.

[0094] After the above steps are completed, an optical detection device is used to obtain an optical image of the probe reaction layer, see AE in Figure 8, which correspond to five different concentrations of the SARS-CoV-2 N protein: 0 ng / mL (corresponding to Figure A in Figure 8), 0.01 ng / mL (corresponding to Figure B in Figure 8), 0.1 ng / mL (corresponding to Figure C in Figure 8), 1 ng / mL (corresponding to Figure D in Figure 8) and 10 ng / mL (corresponding to Figure E in Figure 8).

[0095] Next, the five optical images obtained from the first set of experiments (AE in FIG7 ) and the five optical images obtained from the second set of experiments (AE in FIG8 ) were analyzed using the grayscale averaging method and the single particle counting method, respectively. The analysis results are shown in Table 1.

[0096] Table 1

[0097] Table 1 shows that in the first set of experimental data, the grayscale averaging method yielded a detection result of 67.9 for a concentration of 1 ng / mL, which significantly changed from the 36.7 detection result for a relative concentration of 0.1 ng / mL. The detection results for concentrations below 1 ng / mL, 0-0.1 ng / mL, did not show any significant changes. The single particle counting method yielded a detection result of 64 for a concentration of 0.01 ng / mL, which significantly changed from the 0 detection result. This indicates that, in the first set of experimental data, the grayscale averaging method was most effective at a concentration of 1 ng / mL, or that the grayscale averaging method had a detection sensitivity of 1 ng / mL, and that the detection sensitivity for analytes below 1 ng / mL was relatively low. The single particle counting method was most effective at a concentration of 0.01 ng / mL, or that the single particle counting method had a detection sensitivity of 0.01 ng / mL.

[0098] Similarly, looking at the second set of experimental data, the results obtained using the grayscale averaging method show a significant change at a concentration of 10 ng / mL. However, the results obtained using the single particle counting method show a significant change at a concentration of 0.1 ng / mL. This indicates that the sensitivity of the single particle counting method is approximately 100 times that of the grayscale averaging method.

[0099] Furthermore, the first set of experimental data revealed that when the concentration was greater than 1 ng / mL, the single particle counting method exhibited significant overlap of characteristic bright spots in the corresponding optical images, rendering the single particle counting method ineffective. Therefore, when the concentration of the target substance was high, resulting in a high density of characteristic bright spots, the grayscale averaging method could be used; when the concentration of the target substance was low, resulting in a low density of characteristic bright spots, the single particle counting method could be used.

[0100] It should be noted that the above description of the relevant processes is for illustration and purpose only and does not limit the scope of application of this specification. For those skilled in the art, various modifications and changes can be made to the processes under the guidance of this specification. However, such modifications and changes are still within the scope of this specification.

[0101] While the basic concepts have been described above, it will be apparent to those skilled in the art that the detailed disclosure is merely illustrative and does not limit this specification. Although not explicitly stated herein, various modifications, improvements, and revisions to this specification may be made by those skilled in the art. Such modifications, improvements, and revisions are suggested in this specification and remain within the spirit and scope of the exemplary embodiments of this specification.

[0102] This specification also uses specific terms to describe the embodiments of this specification. For example, "one embodiment," "an embodiment," or "some embodiments" refers to a feature, structure, or characteristic associated with at least one embodiment of this specification. Therefore, it should be emphasized and noted that the mention of "one embodiment," "an embodiment," or "an alternative embodiment" two or more times in different locations in this specification does not necessarily refer to the same embodiment. Furthermore, certain features, structures, or characteristics in one or more embodiments of this specification may be appropriately combined.

[0103] In addition, unless expressly stated in the claims, the order of the processing elements and sequences, the use of alphanumeric characters, or the use of other names described in this specification are not intended to limit the order of the processes and methods of this specification. Although the above disclosure discusses some of the invention embodiments currently considered useful through various examples, it should be understood that such details are for illustrative purposes only, and the appended claims are not limited to the disclosed embodiments. On the contrary, the claims are intended to cover all modifications and equivalent combinations that are consistent with the spirit and scope of the embodiments of this specification. For example, although the system components described above can be implemented by hardware devices, they can also be implemented only by software solutions, such as installing the described system on an existing server or mobile device.

[0104] Similarly, it should be noted that, in order to simplify the presentation of this specification and thus facilitate understanding of one or more embodiments of the invention, the foregoing descriptions of the embodiments of this specification sometimes combine multiple features into a single embodiment, figure, or description thereof. However, this disclosure method does not imply that the subject matter of this specification requires more features than those recited in the claims. In fact, an embodiment may have fewer features than all of the features of a single disclosed embodiment.

[0105] In some embodiments, numbers are used to describe the quantity of components and attributes. It should be understood that such numbers used in the description of the embodiments are modified by the modifiers "about", "approximately" or "substantially" in some examples. Unless otherwise stated, "about", "approximately" or "substantially" indicate that the numbers are allowed to vary by ±20%. Accordingly, in some embodiments, the numerical parameters used in the description and claims are approximate values, which may change according to the required characteristics of individual embodiments. In some embodiments, the numerical parameters should take into account the specified significant digits and adopt the general method of retaining digits. Although the numerical domains and parameters used to confirm the breadth of their range in some embodiments of this specification are approximate values, in specific embodiments, the settings of such numerical values ​​are as accurate as possible within the feasible range.

[0106] Each patent, patent application, patent application publication, and other materials, such as articles, books, specifications, publications, and documents, cited in this specification is hereby incorporated by reference in its entirety. This includes application history documents that are inconsistent with or conflict with the content of this specification, as well as documents (currently or subsequently attached to this specification) that limit the broadest scope of the claims of this specification. It should be noted that if the descriptions, definitions, and / or terminology used in the accompanying materials are inconsistent or conflicting with the content of this specification, the descriptions, definitions, and / or terminology used in this specification will control.

[0107] Finally, it should be understood that the embodiments described in this specification are intended only to illustrate the principles of the embodiments of this specification. Other variations may also fall within the scope of this specification. Therefore, by way of example and not limitation, alternative configurations of the embodiments of this specification may be considered consistent with the teachings of this specification. Accordingly, the embodiments of this specification are not limited to the embodiments explicitly described and illustrated in this specification.

Claims

1. A digital detection method, characterized in that: The method comprises: Providing a probe having a capture ligand fixed thereto and a container for containing a liquid; The probe and the first container are moved relative to each other to capture the object to be detected in the solution in the first container; The probe and the second container are moved relative to each other to capture the detection ligand in the solution in the second container, wherein the detection ligand is directly or indirectly coupled to a luminescent marker; Detecting the optical signal of the luminescent marker of the probe reaction layer by an optical detection device, converting the optical signal into a digital signal, and counting the number of the luminescent markers based on the digital signal to determine the concentration of the detected object; The capture ligand binds to a first site of the object to be detected, and the detection ligand binds to a second site of the object to be detected.

2. The digital detection method according to claim 1, characterized in that: The relative motion of the probe or the container includes one or more of up-and-down reciprocating motion, left-and-right reciprocating motion, and orbital motion according to a preset radius.

3. The digital detection method according to claim 1, characterized in that: The probe comes into contact with the liquid in the container.

4. The digital detection method according to claim 1, characterized in that: The reaction layer for fixing the capture ligand is arranged on the bottom end surface or the bottom side surface of the probe in contact with the liquid in the container.

5. The digital detection method according to claim 1, characterized in that: The container 1 and the container 2 are different containers; the relative movement between the probe and the container 2 occurs after the relative movement between the probe and the container 1 in terms of time.

6. The digital detection method according to claim 1, characterized in that: The first container and the second container are the same container; the object to be detected in the first container and the detection ligand in the second container are in a solution in the same container.

7. The digital detection method according to claim 1, characterized in that: After the relative movement of the probe and the container, the cleaning process is completed in the cleaning liquid in the additional container.

8. The digital detection method according to claim 1, characterized in that: The capture ligand includes one or more of a compound, an antibody, an antigen, a protein, a cell, a virus, a bacterium, a nucleic acid and a nucleic acid aptamer; and the detection ligand includes one or more of a compound, an antibody, an antigen, a protein, a cell, a virus, a bacterium, a nucleic acid and a nucleic acid aptamer.

9. The digital detection method according to claim 1, characterized in that: The capture ligand includes antibody 1, the detection ligand includes antibody 2, and the object to be detected includes an antigen; the antibody 1 and the antibody 2 can bind to different sites of the antigen.

10. The digital detection method according to claim 1, characterized in that: The number of the probes is one or more.

11. The digital detection method according to claim 1, characterized in that: The number of the containers is one or more.

12. The digital detection method according to claim 1, characterized in that: The material of the probe fixed with the capture ligand is a single component or multiple components of glass, quartz, plastic, rubber, ceramic, or metal.

13. The digital detection method according to claim 1, characterized in that: The optical signal is detected by the optical detection device while suppressing the background signal by utilizing the luminescence mechanism of the marker.

14. The digital detection method according to claim 13, characterized in that: The luminescent marker is an up-conversion luminescent nanoparticle.

15. The digital detection method according to claim 14, characterized in that: The particle size of the up-conversion luminescent nanoparticles is 1 nm to 500 nm.

16. The digital detection method according to claim 1, characterized in that: When the density of the luminescent marker is within a preset range, the optical detection device counts the number of characteristic bright spots of the luminescent marker. When the density of the luminescent marker is outside the preset range, the optical detection device measures the overall luminous intensity of the luminescent marker to determine the concentration information of the object being detected.

Citation Information

Patent Citations

  • Binding assays utilizing time-resolved up-converting luminescence detection

    CN103278481A

  • Single-molecule immunodetection method based on up-conversion fluorescence probe

    CN111735964A

  • Monomolecular fluorescence detection technology based on nano up-conversion material

    CN114778496A

  • Solid-phase extraction device for immunoassay, integrated device and application of solid-phase extraction device

    CN114778827A

  • Automated detection and counting of biomolecules using nanoparticle probes

    US20120046191A1